Generation Bio Co. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was USD 31.07 million compared to USD 37.93 million a year ago. Basic loss per share from continuing operations was USD 0.47 compared to USD 0.66 a year ago. Diluted loss per share from continuing operations was USD 0.47 compared to USD 0.66 a year ago.
For the six months, net loss was USD 63.16 million compared to USD 72.93 million a year ago. Basic loss per share from continuing operations was USD 1 compared to USD 1.28 a year ago. Diluted loss per share from continuing operations was USD 1 compared to USD 1.28 a year ago.